Soleno Therapeutics Inc

NASDAQ:SLNO

1.02

+0.01 (+0.99%)

6:13:04 PM EDT: $1.05 +0.03 (+2.94%)

Soleno Therapeutics Inc Stock, NASDAQ:SLNO

203 Redwood Shores Parkway, Suite 500, Redwood City, California 94065

United States of America

Phone: +1.650.213.8444

Number of Employees: 31

http://www.soleno.life

Description

Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. The firm focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.